5.05k 個跟隨者 • 31 個股票代號 追蹤清單由 Yahoo Finance 提供
Thermo Fisher Scientific Inc.
Intuitive Surgical, Inc.
Boston Scientific Corporation
Becton, Dickinson and Company
Edwards Lifesciences Corporation
IDEXX Laboratories, Inc.
IQVIA Holdings Inc.
Agilent Technologies, Inc.
Zimmer Biomet Holdings, Inc.
West Pharmaceutical Services, Inc.
Align Technology, Inc.
Baxter International Inc.
Laboratory Corporation of America Holdings
ICON Public Limited Company
Koninklijke Philips N.V.
The Cooper Companies, Inc.
Quest Diagnostics Incorporated
The market sent bullish signals last week. Crude prices jumped as Saudi Arabia cut output. Apple and Palo Alto have big news. Tesla is in a buy zone.
In this piece, we will take a look at the ten internet of things (IoT) stocks billionaires are loading on. For more IoT stocks, head on over to 5 Internet of Things (IoT) Stocks Billionaires Are Loading Up On. As a technology, the consumer use of the Internet is entering its fourth decade. And over […]
Dividend Kings are among the most steady corporations on the market. While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least 50 consecutive years to become a member of this elite group. Case in point: Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) are two members of this prominent clique that have lagged the market recently, partly due to company-specific concerns.
Becton Dickinson's (NYSE:BDX) stock up by 6.6% over the past three months. We wonder if and what role the company's...
The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...
Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch.
The EV giant broke out this week, leading a group of stocks around buy points as the market rally attempts to gather steam.
Let's consider three stocks that could: Vertex Pharmaceuticals (NASDAQ: VRTX), DexCom (NASDAQ: DXCM), and Amazon (NASDAQ: AMZN). Vertex Pharmaceuticals is doing great things. One of the drugmakers that was closest to entering this market with competing products recently threw in the towel.
Medtronic (NYSE: MDT) has grown revenue over the years thanks to its solid portfolio of medical devices. Medtronic has taken action, streamlining parts of the business and acquiring assets that could drive future revenue. Medtronic is incorporating AI into its devices more and more.
In the latest trading session, Align Technology (ALGN) closed at $302, marking a +1.62% move from the previous day.
Thermo Fisher Scientific (TMO) closed at $520.14 in the latest trading session, marking a +0.15% move from the prior day.
Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by Illumina Inc, said the letters were mistakenly sent by PWNHealth due to a software issue and that it "was in no way related to or caused by an incorrect Galleri test result".
About 400 patients who signed up to take cancer diagnostic test maker Grail's pioneering oncology detection test received erroneous letters suggesting they may have developed cancer, the company said on Friday. Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by Illumina Inc, said the letters were mistakenly sent by its telemedicine provider PWNHealth due to a software issue and that it "was in no way related to or caused by an incorrect Galleri test result".
Q2 2023 Cooper Companies Inc Earnings Call
Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.
PacBio's (PACB) product development activities raise optimism about the stock.
In this article, we will discuss the best dividend aristocrat stocks sorted by hedge fund popularity. You can skip our detailed analysis of dividend aristocrats and their past performance, and go directly to read S&P 500 Dividend Aristocrats List: Top 10 Among Hedge Funds. Dividend aristocrats are companies in the S&P 500 that have a […]
Cooper Companies' (COO) second-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Global Healthcare Conference. Jim Davis, Chairman, CEO and President, will discuss recent market developments and trends as well as the company's performance and strategy. The presentation is scheduled for Thursday, June 8, 2023, at 2:30 p.m. Eastern Time.
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. PrimateAI-3D utilizes deep neural network architectures similar to ChatGPT and AlphaFold, but is trained on genome sequences rather than human language. After applying the algorithm to half a million genomes in the U.K. Biobank cohort detailing the training, the results showed unprecedented accuracy. The result is a deep neural network that h
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and its strategies to accelerate growth.
SANTA CLARA, Calif., June 02, 2023--Agilent Technologies Inc. (NYSE: A) today announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics, being held June 4 - 8 in Houston, Texas. Agilent is a global leader in the mass spectrometry market, providing advanced, intelligent instruments featuring improved analytical performance solutions for analytical labs worldwide.
Illumina Inc on Friday said it had expanded its board, adding two C-suite executives a week after shareholders voted to replace the gene sequencing company's chairman with activist investor Carl Icahn's nominee. On Friday it named Stephen MacMillan, CEO of diagnostics products company Hologic Inc, and Scott Ullem, CFO of heart valve systems maker Edwards Lifesciences Corp, as new directors.
On Friday it named Stephen MacMillan, CEO of diagnostics products company Hologic Inc, and Scott Ullem, CFO of heart valve systems maker Edwards Lifesciences Corp, as new directors. Wall Street analysts welcomed the move, with analysts at Evercore ISI writing: "Steve and Scott are well known and respected by Wall Street and should bring a ton of confidence into the (Illumina) story."